Intravacc

Bilthoven, Netherlands Founded: 2012 • Age: 14 yrs
Vaccine development services for bacterial and viral vaccines are provided.
Request Access

About Intravacc

Intravacc is a company based in Bilthoven (Netherlands) founded in 2012.. Intravacc offers products and services including Process Development, Analytical Method Development, and GMP Manufacturing. Intravacc operates in a competitive market with competitors including Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Primrose Bio, among others.

  • Headquarter Bilthoven, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $633 K (USD), Grant

    Jan 16, 2024

  • Investors
    CARB-X

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Intravacc

Intravacc offers a comprehensive portfolio of products and services, including Process Development, Analytical Method Development, and GMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops vaccine processes from discovery to clinical trials

Creates methods for vaccine quality and analysis

Produces vaccines under regulated manufacturing standards

People of Intravacc
Headcount 50-200
Employee Profiles 23
Employee Profiles
People
Jenneke Smit
Consultant Clinical Research - Clinical Trial Manager
People
Josse van Galen
Scientist Analytical Biochemistry, Assay Development
People
Eelke Bouma
Research Assistant DSP
People
Tim Bindels
Research Technician at Department of Translational Research

Unlock access to complete

Funding Insights of Intravacc

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $633,000
  • First Round

    (06 Jul 2022)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Grant - Intravacc Valuation

investors

Jul, 2022 Amount Grant - Intravacc Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Intravacc

Intravacc has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include CARB-X and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Antibiotics, vaccines, and diagnostics against drug-resistant bacteria are developed.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Intravacc

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Intravacc

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Intravacc Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Intravacc

Intravacc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Primrose Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Vaccine manufacturing services are provided by Neovacs CDMO.
domain founded_year HQ Location
Biotechnology company specializing in bioconjugation services mainly for vaccine development
domain founded_year HQ Location
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
domain founded_year HQ Location
Contract manufacturing of bio-therapeutics and vaccines is provided.
domain founded_year HQ Location
New molecules are discovered, developed, and manufactured in biotechnology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Intravacc

Frequently Asked Questions about Intravacc

When was Intravacc founded?

Intravacc was founded in 2012 and raised its 1st funding round 10 years after it was founded.

Where is Intravacc located?

Intravacc is headquartered in Bilthoven, Netherlands. It is registered at Bilthoven, Utrecht, Netherlands.

What does Intravacc do?

Intravacc was founded in 2012 and is based in Bilthoven, Netherlands. Operations focus on the biotechnology sector, where bacterial and viral vaccines are developed using the Vero cell line, along with conjugation and adjuvants. Assay development, vaccine characterization, and pilot-scale manufacturing are offered, as well as 3R research in animal models. Platforms such as OMV technology, Vero cell, and iBoost technology are utilized.

Who are the top competitors of Intravacc?

Intravacc's top competitors include Neovacs, Yapanbio and VERAXA.

What products or services does Intravacc offer?

Intravacc offers Process Development, Analytical Method Development, and GMP Manufacturing.

Who are Intravacc's investors?

Intravacc has 2 investors. Key investors include CARB-X, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available